ArticleMethods in molecular biology (Clifton, N.J.)2026
Preparation and Detection of Designed DNA Carriers for Nanopore Sensing.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Single-molecule detection is a powerful strategy for early disease diagnosis, allowing the specific identification of nucleic acids and proteins. While nanopore technology enables fluorescent label-free, high-resolution analysis of individual biomolecules, its lack of intrinsic molecular selectivity limits performance in complex biological samples. The DNA carrier strategy addresses this limitation by introducing target recognition capability, incorporating molecular barcodes, and enhancing signal clarity in complex backgrounds. When combined with low-noise, high-resolution glass nanopores, these carriers enable specific and multiplexed biomarker detection for early-stage cancer and other diseases. This chapter presents a detailed and standardized protocol for preparing and detecting assembled DNA carriers using nanopores, providing an accessible workflow for broader adoption in single-molecule sensing and molecular diagnostics.
Indexed as
Identifiers
42663958What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.